13 June 2017
Proveca and Tanner Pharma Initiate Global Managed Access Program for Sialanar®
CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group’s Managed Access Programs (MAP) division and Proveca have agreed to launch a Managed Access Program for an oral formulation of glycopyrronium (Sialanar®) outside Europe and the USA. Sialanar is for the treatment of...
6 June 2017
Bioverativ to acquire True North Therapeutics and the Abzena Inside portfolio product, TNT009
Cambridge, UK, 24 May 2017 – Abzena plc (AIM: ABZA, ‘Abzena’ or the ‘Group’), the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, notes the announcement from Bioverativ...
24 May 2017
Proctors Transport see vast savings & 100% compliance since using r2c Online’s digital Driver solution.
Proctors Transport, road haulage and freight distribution specialists, are the latest to see vast savings & 100% compliance since using r2c Online’s digital Driver solution. r2c’s innovative Digital Driver Check app has been designed with optimum compliance, ROI...
23 May 2017
Yospace and MTM launch the linear IP video forum at Connected TV World Summit
Connected TV World Summit, London, UK – 18th May 2017 … Yospace and MTM are pleased to announce an exciting new research programme exploring the evolution of the linear and live video streaming market across Europe. The programme will look to answer questions that include:
27 April 2017
Abzena to pursue $12 million investment program to upgrade and expand its San Diego biomanufacturing operations
San Diego CA, USA, 26 April 2017 – Abzena intends to invest $12 million at its San Diego facilities in order to upgrade and expand its biomanufacturing capabilities and capacity to meet increasing customer demand for its services. This investment was made possible...
25 April 2017
Blueberry Therapeutics commence Phase I-II clinical trial of lead product BB2603
Blueberry Therapeutics are pleased to announce they have dosed the first patient in a Phase I/II clinical trial of BB2603 in fungal infection of the skin and nail following successful regulatory and ethics approvals. The trial, which is a safety and efficacy study in...
13 April 2017
Catapult portfolio company, Hangar Seven, acquired by The Hut Group
Catapult is pleased to announce that its portfolio business, Hangar Seven Limited, a marketing services agency specialising in content creation has been acquired by The Hut Group, and has delivered an excellent return for the Catapult Growth Fund with a 3 times cash return.
30 March 2017
Proveca raises £4m led by Catapult Ventures to launch children’s drug Sialanar in Europe and accelerate children’s medicines pipeline
Manchester, UK – 29th March 2017. Proveca, a European paediatric speciality pharmaceutical company, today announced that it has raised £4m to fund the commercial launch of Sialanar™ and the development and commercialisation of its paediatric product portfolio.
16 March 2017
Catapult generates 3.5x return from sale of Monica Healthcare
Catapult Ventures is delighted to announce that portfolio company, Monica Healthcare Ltd, the global leader in foetal monitoring, has been acquired by GE Healthcare. The cash purchase will generate returns of 3.5x for the East Midlands Regional Venture Capital Fund, managed by...
1 March 2017
Catapult Sells Silver Lining Solutions to US Based Genesys®
Catapult is pleased to announce that its portfolio business, Silver Lining Solutions Limited, a Midlands based provider of employee performance optimisation software, has been acquired by US based Genesys®. Silver Lining Solutions is a developer of employee optimisation...